 | ProPhase Labs, Inc. | |||
| NCM : PRPH || Location: United States | ||||
$4.95-0.11 (-2.17%) |
0.01 M | 4.9 - 5.11 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.275 M |
| March 28, 2024 | 0.257 M |
| March 15, 2024 | 0.248 M |
| Feb. 29, 2024 | 0.298 M |
| Feb. 15, 2024 | 0.296 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.27 | -0.51 | -92.31% |
| 09/30/2023 | -0.20 | -0.30 | -50.83% |
| 06/30/2023 | -0.14 | -0.20 | -40.06% |
| 03/31/2023 | -0.10 | 0.03 | 129.41% |
| 12/31/2022 | 0.03 | -0.12 | -570.59% |
Recent Dividends
| Div Date | Div Amount |
|---|---|
| 05/24/2022 | 0.30 |
| 02/28/2022 | 0.30 |
| 05/24/2021 | 0.30 |
| 12/02/2019 | 0.25 |
| 01/09/2019 | 0.25 |
PRPH Basic Data
| Sector | Healthcare | Industry | Diagnostics & Research |
| Shares Outstanding | 18.045M | Shares Float | 14.050M |
| Short Float | 0.275M | Market Cap | 91.31M |
| Institution ownership | 9.54% | Insider ownership | 22.056% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.98 | Forward EPS | 0.48 |